Caseware UK (AP4) 2023.0.135 2023.0.135 2024-03-312024-03-312023-04-01true00falsefalse 05410890 2023-04-01 2024-03-31 05410890 2022-04-01 2023-03-31 05410890 2024-03-31 05410890 2023-03-31 05410890 2022-04-01 05410890 c:Director1 2023-04-01 2024-03-31 05410890 c:Director2 2023-04-01 2024-03-31 05410890 c:Director3 2023-04-01 2024-03-31 05410890 c:RegisteredOffice 2023-04-01 2024-03-31 05410890 d:CurrentFinancialInstruments 2024-03-31 05410890 d:CurrentFinancialInstruments 2023-03-31 05410890 d:ShareCapital 2023-04-01 2024-03-31 05410890 d:ShareCapital 2024-03-31 05410890 d:ShareCapital 2022-04-01 2023-03-31 05410890 d:ShareCapital 2023-03-31 05410890 d:ShareCapital 2022-04-01 05410890 d:RetainedEarningsAccumulatedLosses 2023-04-01 2024-03-31 05410890 d:RetainedEarningsAccumulatedLosses 2024-03-31 05410890 d:RetainedEarningsAccumulatedLosses 2022-04-01 2023-03-31 05410890 d:RetainedEarningsAccumulatedLosses 2023-03-31 05410890 d:RetainedEarningsAccumulatedLosses 2022-04-01 05410890 c:OrdinaryShareClass1 2023-04-01 2024-03-31 05410890 c:OrdinaryShareClass1 2024-03-31 05410890 c:OrdinaryShareClass1 2023-03-31 05410890 c:EntityNoLongerTradingButTradedInPast 2023-04-01 2024-03-31 05410890 c:FRS102 2023-04-01 2024-03-31 05410890 c:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 05410890 c:FullAccounts 2023-04-01 2024-03-31 05410890 c:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 05410890 e:PoundSterling 2023-04-01 2024-03-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 05410890









THE ESSENTIAL PHARMACY LTD







UNAUDITED

DIRECTORS' REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

 
THE ESSENTIAL PHARMACY LTD
 
 
COMPANY INFORMATION


Directors
Miss H Patel 
Mr J C Patel Jnr 
Mr K C Patel Jnr 




Registered number
05410890



Registered office
2 Peterwood Way
Croydon

Surrey

CR0 4UQ





 
THE ESSENTIAL PHARMACY LTD
 

CONTENTS



Page
Directors' Report
1
Profit and Loss Account
2
Balance Sheet
3
Statement of Changes in Equity
4
Notes to the Financial Statements
5 - 6


 
THE ESSENTIAL PHARMACY LTD
 
 
 
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 MARCH 2024

The Directors present their report and the financial statements for the year ended 31 March 2024.

Principal activity

The principal activity of the Company continued to be that of a dormant company.

Results and dividends

The profit for the year, after taxation, amounted to £NIL (2023 - £NIL).

The Directors recommend a final dividend of £685,670 (2023 - £NIL) to be paid for the year.

Directors

The Directors who served during the year were:

Miss H Patel 
Mr J C Patel Jnr 
Mr K C Patel Jnr 

Small companies note

In preparing this report, the Directors have taken advantage of the small companies exemptions provided by section 415A of the Companies Act 2006.

This report was approved by the board and signed on its behalf.
 





Mr J C Patel Jnr
Director

Date: 1 October 2024

Page 1

 
THE ESSENTIAL PHARMACY LTD
 
 
PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 31 MARCH 2024

The Company has not traded during the year or the preceding financial year. During these periods, the Company received no income and incurred no expenditure other than exempted payments under the provisions of section 1169 (3)(b) of the Companies Act 2006.

The notes on pages 5 to 6 form part of these financial statements.

Page 2

 
THE ESSENTIAL PHARMACY LTD
REGISTERED NUMBER: 05410890

BALANCE SHEET
AS AT 31 MARCH 2024

2024
2023
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 3 
100
685,770

  
100
685,770

Total assets less current liabilities
  
 
 
100
 
 
685,770

  

Net assets
  
100
685,770


Capital and reserves
  

Called up share capital 
 4 
100
100

Profit and loss account
  
-
685,670

  
100
685,770


For the year ended 31 March 2024 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The Directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The Company's financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




Mr J C Patel Jnr
Director

Date: 1 October 2024

The notes on pages 5 to 6 form part of these financial statements.

Page 3

 
THE ESSENTIAL PHARMACY LTD
 

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2024


Called up share capital
Profit and loss account
Total equity

£
£
£

At 1 April 2023
100
685,670
685,770
Total comprehensive income for the year
-
-
-


Contributions by and distributions to owners

Dividends: Equity capital
-
(685,670)
(685,670)


At 31 March 2024
100
-
100



STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2023


Called up share capital
Profit and loss account
Total equity

£
£
£

At 1 April 2022
100
685,670
685,770
Total comprehensive income for the year
-
-
-


At 31 March 2023
100
685,670
685,770


The notes on pages 5 to 6 form part of these financial statements.

Page 4

 
THE ESSENTIAL PHARMACY LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1.


General information

The Essential Pharmacy Ltd (the "Company") is a private company limited by shares and incorporated, domiciled and registered in England in the United Kingdom. The address of the registered office is given on the company information page. The nature of the company's operations and its principal activities are set out in the directors' report on page 1.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The functional currency of the Company is considered to be pounds sterling because that is the currency of the primary economic environment in which the Company operates. The financial statements are also presented in pounds sterling and rounded to the nearest £.

The following accounting policies have been applied:

  
2.2

Financial Reporting Standard 102 - reduced disclosure exemptions

The Company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by the FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":
the requirements of Section 7 Statement of Cash Flows;
the requirements of Section 3 Financial Statement Presentation paragraph 3.17(d);
the requirements of Section 11 Financial Instruments paragraphs 11.42, 11.44 to 11.45, 11.47,
11.48(a)(iii), 11.48(a)(iv), 11.48(b) and 11.48(c);
the requirements of Section 12 Other Financial Instruments paragraphs 12.26 to 12.27, 12.29(a), 12.29(b) and 12.29A; and
the requirements of Section 33 Related Party Disclosures paragraph 33.7.

This information is included in the consolidated financial statements of Day Lewis Plc as at 31 March 2024 and these financial statements may be obtained from 2 Peterwood Way, Croydon, Surrey, CR0 4UQ.

 
2.3

Going concern

As the Directors do not intend to acquire a replacement trade, the Directors have not prepared the financial statements on a going concern basis.

 
2.4

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

Page 5

 
THE ESSENTIAL PHARMACY LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

3.


Debtors

2024
2023
£
£


Amounts owed by group undertakings
100
685,770

100
685,770



4.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



100 (2023 - 100) Ordinary shares of £1.00 each
100
100



5.


Controlling party

The Company's immediate parent company is Day Lewis Plc, a company registered in England and Wales. It prepares group financial statements which are available at Day Lewis House, 2 Peterwood Way, Croydon, Surrey CR0 4UQ.
The smallest and largest group in which the results of the Company and its group are consolidated in publicly available group financial statements is that headed by Day Lewis Plc, Day Lewis House, 2 Peterwood Way, Croydon, Surrey, CR0 4UQ.
The ultimate parent company is Day Lewis Holdings Limited, a company registered in Cyprus and controlled by the KCTP Will Trust.
Copies of the ultimate parent's financial statements are not publicly available.

Page 6